Bulk Rituximab Monoclonal Antibody from Mexico
Rituximab targets CD20 on B-cells for lymphoma and autoimmune treatment, a biotech-produced antibody. As an unmixed product not for retail, it fits HTS 3002.13.00 immunological products definition.
Duty Rate — Mexico → United States
100%
Rate breakdown
9903.04.60100%Except as provided in heading 9903.04.61, patented pharmaceutical articles as provided for in subdivisions (c) and (d) of U.S. note 40 to this subchapter
9903.05.860%Articles provided for in subdivision (b) of U.S. note 52 to this subchapter
Import Tips
• Ensure BLA (Biologics License Application) reference; provide glycosylation profile analysis; declare bulk quantity to affirm non-retail status